Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications

Citation
R. Donnellan et al., Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications, HUMAN PATH, 32(1), 2001, pp. 89-94
Citations number
21
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
HUMAN PATHOLOGY
ISSN journal
00468177 → ACNP
Volume
32
Issue
1
Year of publication
2001
Pages
89 - 94
Database
ISI
SICI code
0046-8177(200101)32:1<89:CEIIBD>2.0.ZU;2-#
Abstract
Abnormalities of the cell cycle are present in all neoplasms. Cyclin E, whi ch regulates the G1/S phase transition of the cell cycle, plays an importan t role in many different cancers. To further investigate the role of cyclin E in invasive breast ductal carcinomas in South African women, representat ive sections from 157 mastectomy and axillary clearance specimens were stai ned with the cyclin E antibody. The results were compared with known clinic opathologic prognostic factors, namely lymph node metastases, size, estroge n receptor status, and histologic grade. Positive (nuclear) cyclin E immuno staining strongly correlates with negative estrogen receptor status and hig h grade. These correlations may account for the observation that although c yclin E staining is associated with poor prognosis in univariate analysis, no prognostic significance remains after multivariate analysis. Copyright ( C) 2001 by W.B. Saunders Company.